Eastern Bank Sells 1,425 Shares of The Clorox Company $CLX

Eastern Bank lessened its position in shares of The Clorox Company (NYSE:CLX) by 24.6% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 4,362 shares of the company’s stock after selling 1,425 shares during the period. Eastern Bank’s holdings in Clorox were worth $524,000 at the end of the most recent reporting period.

Other hedge funds have also bought and sold shares of the company. Simplicity Wealth LLC grew its holdings in Clorox by 157.3% in the second quarter. Simplicity Wealth LLC now owns 18,316 shares of the company’s stock worth $2,199,000 after purchasing an additional 11,198 shares during the period. Raymond James Financial Inc. grew its holdings in Clorox by 15.6% in the first quarter. Raymond James Financial Inc. now owns 269,926 shares of the company’s stock worth $39,747,000 after purchasing an additional 36,352 shares during the period. OneDigital Investment Advisors LLC acquired a new stake in Clorox in the first quarter worth $247,000. Brown Miller Wealth Management LLC acquired a new stake in Clorox in the first quarter worth $399,000. Finally, Roman Butler Fullerton & Co. acquired a new stake in Clorox in the first quarter worth $400,000. Institutional investors own 78.53% of the company’s stock.

Insiders Place Their Bets

In related news, COO Eric H. Reynolds sold 15,041 shares of the business’s stock in a transaction dated Thursday, September 4th. The shares were sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the transaction, the chief operating officer directly owned 54,221 shares in the company, valued at approximately $6,711,475.38. The trade was a 21.72% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 0.57% of the company’s stock.

Analyst Ratings Changes

CLX has been the subject of a number of research reports. Jefferies Financial Group reduced their price target on shares of Clorox from $167.00 to $145.00 and set a “buy” rating for the company in a report on Thursday, June 26th. TD Cowen reduced their price target on shares of Clorox from $120.00 to $117.00 and set a “hold” rating for the company in a report on Wednesday, October 1st. JPMorgan Chase & Co. reduced their price target on shares of Clorox from $135.00 to $127.00 and set a “neutral” rating for the company in a report on Friday. Wells Fargo & Company reduced their price objective on shares of Clorox from $130.00 to $125.00 and set an “equal weight” rating for the company in a report on Thursday, September 25th. Finally, UBS Group reduced their price objective on shares of Clorox from $134.00 to $128.00 and set a “neutral” rating for the company in a report on Wednesday. One equities research analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and three have given a Sell rating to the company’s stock. According to data from MarketBeat, Clorox currently has an average rating of “Reduce” and an average target price of $131.92.

Clorox Stock Up 0.1%

Shares of NYSE CLX opened at $120.14 on Friday. The stock has a market capitalization of $14.63 billion, a P/E ratio of 18.43, a P/E/G ratio of 0.98 and a beta of 0.52. The company has a 50-day moving average price of $122.21 and a 200-day moving average price of $128.69. The Clorox Company has a 1 year low of $116.53 and a 1 year high of $171.37. The company has a debt-to-equity ratio of 5.15, a current ratio of 0.84 and a quick ratio of 0.57.

Clorox (NYSE:CLX) last released its quarterly earnings results on Thursday, July 31st. The company reported $2.87 earnings per share for the quarter, topping the consensus estimate of $2.24 by $0.63. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The business had revenue of $1.99 billion for the quarter, compared to analysts’ expectations of $1.94 billion. During the same period in the previous year, the company earned $1.82 earnings per share. The firm’s revenue for the quarter was up 4.5% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. On average, equities research analysts forecast that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, November 6th. Investors of record on Wednesday, October 22nd will be issued a dividend of $1.24 per share. The ex-dividend date is Wednesday, October 22nd. This represents a $4.96 annualized dividend and a yield of 4.1%. Clorox’s payout ratio is 76.07%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.